Skip to content
Trial Eligibility
Menu

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

NCT07365514

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Postmenopausal Osteoporosis
  • Gut Microbiome
  • Menopause

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
45 to 70 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of Connecticut
Last updated on ClinicalTrials.gov
July 23, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 1

  • University of Connecticut, Department of Nutritional Sciences · Storrs, CT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.